Using this mouse model, we have previously shown that the candidate ovarian cancer preventive progestin not only markedly inhibited the development of fallopian tube cancer but also eradicated histologically normal-appearing FTE cells with abnormal p53, the genetic alteration thought to represent the earliest putative event in fallopian tube carcinogenesis [15]. This evidence concerns the gene TP53 and ovarian carcinoma.